Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ISPC | US
0.00
0.69%
Healthcare
Diagnostics & Research
30/06/2024
06/03/2026
0.25
0.25
0.25
0.24
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids tissues and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals labs biobanks blood centers and other healthcare organizations. The company develops and operates iSpecimen Marketplace a proprietary online marketplace platform that connects medical researchers who need access to subjects samples and data with hospitals laboratories and other organizations who have access to them. It serves biopharmaceutical companies in vitro diagnostic companies and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington Massachusetts.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
112.5%1 month
93.1%3 months
117.8%6 months
270.3%-
-
0.44
0.00
0.00
0.43
0.05
-
-10.03M
162.86K
162.86K
-
-76.18
-
76.20
-98.03
0.25
11.03
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.09
Range1M
0.22
Range3M
0.30
Rel. volume
0.12
Price X volume
64.36K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| T2 Biosystems Inc | TTOO | Diagnostics & Research | 0.01 | 174.80K | 0.05 | -325.87% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.43 | - | Cheaper |
| Ent. to Revenue | 0.05 | - | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.44 | 77.50 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 117.84 | - | Riskier |
| Debt to Equity | 0.00 | -14.36 | Expensive |
| Debt to Assets | 0.00 | 0.34 | Cheaper |
| Market Cap | 162.86K | - | Emerging |